Nisha Unni

6PUBLICATIONS
70CO-AUTHORS
Molecular targetsCancer diagnosisMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 06, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.

Komal Jhaveri, Lisa D Eli, Sara A Hurvitz

|Mar 28, 2026
Assessment of Early Breast Cancer Response to Chemotherapy with Ultrasound Radiomics.

Swapnil Dolui, Basak Dogan, Corinne Wessner

|Mar 07, 2026
Optimized Detection of Left Ventricular Hyperpolarized [1-13C]Pyruvate Signal in Human Cardiac Metabolic Imaging.

Fatemeh Khashami, Ivan E Dimitrov, Maximilian Fuetterer

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|Feb 24, 2025
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.

Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni

|Mar 30, 2023
Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy.

Christopher Johns, Steven K Montalvo, M'Kay Cauble

Pageof 1